Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT07611812
Real-World Patterns of Utilization of Lenalidomide-based Triplet Regimens in FIrst RElapsed Multiple Myeloma Patients: Evidence From Medical Record Review
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
View on ClinicalTrials.gov
Summary
To compare progression-free survival (PFS) in patients with first-relapse multiple myeloma treated with Rd-based "triplets" (Daratumumab + Rd (DaraRd) vs Carfilzomib + Rd (KRd) vs. Elotuzumab + Rd (EloRd) vs. Ixazomib + Rd (IxaRd))
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2021-02-04
Completion Date
2025-12-31
Last Updated
2026-05-28
Healthy Volunteers
Not specified
Locations (1)
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy